A5061506752- Neuroendocrine Tumor Research Advances
- Lung Cancer Research Studies
- Colorectal and Anal Carcinomas
- Colorectal Cancer Treatments and Studies
- Neuroblastoma Research and Treatments
- Gastric Cancer Management and Outcomes
- Pancreatic and Hepatic Oncology Research
- Cancer Treatment and Pharmacology
- Genetic factors in colorectal cancer
- Cancer Genomics and Diagnostics
- Colorectal Cancer Surgical Treatments
- Palliative Care and End-of-Life Issues
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Statistical Methods in Clinical Trials
- Cervical Cancer and HPV Research
- Health Systems, Economic Evaluations, Quality of Life
- Hepatocellular Carcinoma Treatment and Prognosis
- Economic and Financial Impacts of Cancer
- Ethics in Clinical Research
- Childhood Cancer Survivors' Quality of Life
- Pharmaceutical industry and healthcare
- Metastasis and carcinoma case studies
- Pharmaceutical Practices and Patient Outcomes
- Cancer Immunotherapy and Biomarkers
- Cancer Diagnosis and Treatment
AC Camargo Hospital
2017-2025
Universidade de São Paulo
2012-2023
Expro (United Kingdom)
2023
Instituto do Câncer do Estado de São Paulo
2013-2022
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2017-2022
European Neuroendocrine Tumor Society
2019
Hospital Sírio-Libanês
2012-2018
Creative Research Enterprises (United States)
2017
Hospital de Câncer de Barretos
2017
Sociedade Brasileira de Oncologia Clínica
2017
Cancer patients receive numerous medications, including antineoplastic agents, drugs for supportive care, and medications comorbid illnesses. Therefore, they are at risk drug interactions duplicate prescribing.A questionnaire eliciting information on demographics taken in the previous 4 weeks was given to adult outpatients receiving systemic anticancer therapy solid tumors. The Drug Interaction Facts software, version 4.0, used identify potential classify them by level of severity (major,...
Data regarding the diagnosis, management, and follow-up of carcinoid syndrome (CS) heart disease (CHD) were identified by searches MEDLINE database using specific terms in human studies: CS; CHD; screening; epidemiology; diagnosis; treatment; prognosis. The search results supplemented manual searching relevant journals, reference lists key articles other appropriate documents, expert opinion. All recommendations are offered on basis best available evidence, authors' experiences managing CS...
Highlights•Off-target ILDR synergizes with anti-PD-L1 to eradicate non-irradiated tumors•The abscopal effects of depend on dosimetry (≥1 and ≤3 Gy) volume•Gut composition governs the combined anti-PD-L1•ILDR Christensenellaceae influence emigration intestinal mregDC TdLNSummaryThe mechanisms governing local radiotherapy in cancer patients remain an open conundrum. Here, we show that off-target low-dose irradiation (ILDR) increases clinical benefits immune checkpoint inhibitors or...
Background: In patients with breast cancer (BC) undergoing systemic chemotherapy, cancer-related fatigue (CRF) is a common problem that can negatively impact quality of life. Guarana (Paullinia cupana) plant native to the Amazon basin has been used as stimulant since pre-Columbian times.
We performed an open-label single-institution phase II trial of mirtazapine (15-30 mg by mouth [po] every day [qd]), a tetracyclic antidepressant that may lead to weight gain, for 8 weeks in nondepressed patients with cancer-related cachexia/anorexia (CRCA). The primary end point was the proportion who gained ≥1 kg at week 4. Secondary points were quality life and appetite. From June 2006 July 2007, 17 58 eligible enrolled. On intention-to-treat analysis 4, 4 (24%) 1 or more, patient...
A phase 2 trial of gemcitabine and capecitabine (GemCap) in patients with advanced biliary cancer led to an objective response approximately 30% a median survival 14 months. In the current study, authors report further efficacy data larger cohort such treated GemCap regimen.Patients aged >18 years who had diagnosis locally received first-line treatment at dose 650 mg/m(2) twice daily for days 1,000 on Day 1 8, every 3 weeks until disease progression. Tumor was assessed by Response Evaluation...
To identify potential delays in the management of patients with breast cancer examined at a public hospital, from time suspicion until diagnosis and beginning treatment.Retrospective study which analyzed data related to elapsed different intervals between suspicion, onset systemic cancer-directed treatments, consecutive cared for medical oncology clinic Mario Covas Hospital during 2006.Sixty-eight women, mean age 56.3 years (standard deviation: 12.2 years), were included. Of all intervals,...
Abstract Lessons Learned Pregabalin is a medication that can decrease neuronal hyperexcitability, relieve neuropathic pain, and reach stable plasma levels after titration period of only few days. Its use during oxaliplatin infusions was not able to the incidence chronic, oxalipaltin-related compared with placebo. Background Patients colorectal cancer (CRC) receiving (OXA) develop acute chronic painful oxaliplatin-induced peripheral neuropathy (OXAIPN). Acute OXA-related neuropathies have...